Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals Financial Statements

Ionis Pharmaceuticals Financial Overview

Ionis Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.213; its P/E ratio is -213.65; Ionis Pharmaceuticals is scheduled to report earnings on August 9, 2022, and the estimated EPS forecast is $-0.61. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 141.92M$ 440.01M$ 133.09M$ 125.75M$ 111.61M
Gross Profit$ 137.75M$ 437.78M$ 130.01M$ 122.79M$ 109.03M
EBIT$ -63.27M$ 222.10M$ -81.43M$ -78.19M$ -88.24M
EBITDA$ -58.38M$ 227.09M$ -76.73M$ -73.18M$ -83.38M
Net Income Common Stockholders$ -65.17M$ 224.61M$ -82.47M$ -80.88M$ -89.87M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 1.82B$ 1.89B$ 1.99B$ 2.05B$ 2.06B
Total Assets$ 2.52B$ 2.61B$ 2.41B$ 2.50B$ 2.25B
Total Debt$ 627.05M$ 820.66M$ 935.96M$ 1.29B$ 1.31B
Net Debt$ -1.19B$ -1.07B$ -1.05B$ -760.67M$ -748.73M
Total Liabilities$ 1.81B$ 1.84B$ 1.88B$ 1.91B$ 1.57B
Stockholders Equity$ 530.54M$ 582.67M$ 680.56M$ 709.57M$ 743.28M
Cash Flow
Free Cash Flow$ -35.18M$ 199.70M$ -60.17M$ -68.96M$ -57.66M
Operating Cash Flow$ -31.65M$ 203.69M$ -55.57M$ -62.65M$ -54.66M
Investing Cash Flow$ -287.55M$ 95.11M$ 121.97M$ -101.03M$ 78.86M
Financing Cash Flow$ -7.33M$ -62.49M$ 1.46M$ 314.54M$ -7.58M
Currency in USD

Ionis Pharmaceuticals Earnings and Revenue History

Ionis Pharmaceuticals Debt to Assets

Ionis Pharmaceuticals Cash Flow

Ionis Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis